Updated:
Pku Mingde
PKU Mingde focuses on the transformation of high tech from universities and investment in health management, medical drug and new materials. It is a Private...
Pku Mingde
PKU Mingde focuses on the transformation of high tech from universities and investment in health management, medical drug and new materials. It is a Private Equity Firm.
General information
Firm type
Private Equity
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Sector focus
Frequently asked questions
What investment stages does Pku Mingde target?
Pku Mingde operates across a multi-stage mandate that spans seed, venture (general), buyout, and pre-IPO rounds. This lifecycle approach allows the firm to capture early-stage technology emerging from university research and follow portfolio companies through growth equity and control-oriented transitions. The specific stage concentration by fund vehicle has not been publicly disclosed.
How does Pku Mingde relate to Peking University?
The firm is named after Peking University — 'Mingde' references a classical Chinese virtue concept associated with the university — and its investment activity is anchored in the university's technology transfer pipeline. While the exact governance and ownership linkage between the university and the fund manager is not detailed in internationally available records, the affiliation provides a proprietary sourcing channel into faculty-led research spinouts and campus-incubated startups.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: